Rare genetic disease, global health and genomics
The case of R337h in Brazil
in Global health and the new world order
Abstract only
Log-in for full text

You are not authenticated to view the full text of this chapter or article.

manchesterhive requires a subscription or purchase to access the full text of books or journals - to see content that you/your institution should have access to, please log in through your library system or with your personal username and password.

If you are authenticated and think you should have access to this title, please contact your librarian.

Non-subscribers can freely search the site, view abstracts/extracts and download selected front and end matter. 

Institutions can purchase access to individual titles; please contact manchesterhive@manchester.ac.uk for pricing options.

ACCESS TOKENS

If you have an access token for this content, you can redeem this via the link below:

Redeem token

This chapter examines the increasingly visible meeting points between genomics and global health through the lens of rare genetic disease. Focusing on the association between R337h, a particular biomarker that has been identified at high population frequency in Brazil, and a cancer syndrome, it examines how rareness and the politics it enfolds is defined and put to work across terrains of local and global social action. It draws from ethnographic research undertaken in cancer genetic clinics in the south of Brazil with health professionals, scientists and patient communities. It examines the strategic movement between a politics of ‘singularisation’ and ‘numbers’ in how a focus on rare genetic disease is unfolding in this context and the complex vectors through which new yet partial realignments between genomics and global health are being made.

Global health and the new world order

Historical and anthropological approaches to a changing regime of governance

Metrics

All Time Past Year Past 30 Days
Abstract Views 22 22 22
Full Text Views 0 0 0
PDF Downloads 1 1 1